Lapatinib (GW572016) for Metastatic or Recurrent Squamous Cell Carcinoma Esophagus

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00239200
Recruitment Status : Terminated (notification from sponsor)
First Posted : October 14, 2005
Last Update Posted : July 30, 2008
Information provided by:
University of Michigan Rogel Cancer Center

No Study Results Posted on for this Study
  Recruitment Status : Terminated
  Actual Primary Completion Date : June 2006
  Actual Study Completion Date : September 2007